Oncology & Hematology Coding Alert
Statement of Ownership, Management, and Circulation
Published on Tue Oct 01, 2002
Other Articles in this issue of
Oncology & Hematology Coding Alert
- Pump Up Your Billing Reimbursement for Chemo Delivery
The billing rules for chemotherapy delivery systems can seem like so much tangled tubing - but [...] - You Be the Coder:
Chem 18 Panel
Test your coding knowledge. Determine how you would code this situation before looking at the [...] - NHL Radio-Immunotherapy Requires Teamwork
Oncology and radiology teams can now offer people with low-grade, follicular or transformed B-cell non-Hodgkin's [...] - CMS Rule Clears Way for Prothrombin Payment
If confusion over laboratory codes is slowing your reimbursement stream, it's time to get familiar [...] - Dont Accept Frequency Limits
Medicare carriers can no longer deny claims based on frequency limits unless they publish a [...] - Reader Questions:
Anzemet and Oral Anti-Emetics
Question: How should I code for the PO administration of dolasetron (Anzemet)? Virginia Subscriber Answer: [...] - Reader Questions:
Infusion of Cisplatin
Question: We had a patient who received cisplatin in the office and then was sent [...] - Reader Questions:
Brachytherapy Billing
Question: Can I bill 77790 with 77778? If the answer is yes, would you explain [...] - Reader Questions:
Fludara Excess
Question: I have a question regarding the administration of Fludara 50 mg (J9185). At our [...] - Statement of Ownership, Management, and Circulation
View All
